Invloed van het broedproces op het optreden van ascites

De verhoogde gevoeligheid voor het ascitessyndroom door genetische selectie kan worden gekoppeld aan verschillende fysiologische parameters tijdens het embryonaal stadium

Ontogeny of the liver nuclear T3-receptor during the last days of incubation and posthatch in the chick embryo

International audienc

In ovo treatment with an aromatase inhibitor masculinizes postnatal hormone levels, abdominal fat pad content, and GH pulsatility in broiler chickens.

&lt;p&gt;Vorozole, a selective aromatase inhibitor, was administered in ovo to test the specific embryonic role of estrogen in conferring the sex distinction in GH release and body phenotype in broilers. On Day 6 of incubation, eggs were injected with saline or with different concentrations of vorozole. Postnatal blood samples were analyzed for T3, T4, GH, estradiol (E2), and testosterone (T). At the age of 4 wk, control and vorozole-treated birds were cannulated, and serial blood samples were withdrawn every 10 min for 5 hr, wherein GH pulsatility characteristics were determined using deconvolution analysis. The proportional abdominal fat pad weight was reduced significantly in the treated groups, especially in female birds. The vorozole treatment increased plasma T3, E2, T, and GH concentrations, and decreased T4. The frequency of the GH pulses was lower and the interval between the bursts (min) was higher in the vorozole-treated group, as were the mass secreted per burst (ng/ml), the amplitude (ng/ml/min) and the production rate (ng/ml/5 hr). In conclusion, early in ovo treatment with a potent aromatase inhibitor is able to increase the mean serum T3 and GH concentration and masculinize the GH pulse pattern, resulting in an economically favorable decrease in abdominal fat pad content in male and female broilers at slaughter age.&lt;/p&gt;</p

Optimisation of treatment efficiency and effluent toxicity during carbamazepine degradation via electrochemical oxidation

The commercialisation of electrochemical advanced oxidation processes (eAOPs) as a method for removing recalcitrant pollutants from wastewater is currently limited due to the potential for the formation of toxic by-products. In this regard, this research comprised a comprehensive optimisation study aimed at finding a balance between minimising the toxicity effects observed via phytotoxicity assays and maximising the eAOP degradation efficiency under low energy requirements. To this end, carbamazepine (CBZ) was selected as the target pollutant in synthetic wastewater, and the operating conditions considered for optimisation were the nature of the anolyte (i.e., sulfate- or chloride-based), its concentration, and the current density applied. Together with the identification of the CBZ transformation products and their estimated toxicity based on the ECOSAR model, the optimum treatment was found to correspond to the degradation in 500 mg L−1 of a sulfate-based anolyte at a current density of 10 A m−2. These conditions led to the fewest and least toxic transformation products and favoured plant growth indices in phytotoxicity tests. Even if additional process improvements are required to reduce effluent toxicity, continuing such a multi-target optimisation approach can lead to innocuous electrochemical wastewater treatment